search
Back to results

Multidimensional Intervention in Pre-frail Patients Older Than 70 Years

Primary Purpose

Frail Elderly Syndrome, Sarcopenia

Status
Unknown status
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Intensive dietary advice and exercise prescription
Usual dietary advice and exercise prescription
Sponsored by
Endocrinology and Clinical Nutrition Research Center, Spain
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Frail Elderly Syndrome

Eligibility Criteria

70 Years - undefined (Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Non-institutionalized patients over 70 years of age from the basic health area of Medina del Campo Urbano, who meet pre-frailty criteria (1 or 2 Fried criteria).

Exclusion Criteria:

  • Cognitive impairment
  • Frailty syndrome
  • Moderate-Severe Dependence
  • Life Expectancy less than 6 months or patients in palliative care

Sites / Locations

  • Cristina Gutiérrez-LoraRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Intensive dietary advice and exercise prescription

Usual dietary advice and exercise prescription

Arm Description

Personalized dietary advice and exercise prescription according to nutritional status.

Generalized dietary advice and exercise prescription in elder subjects.

Outcomes

Primary Outcome Measures

Functional assessment by Fried Criteria
Test of frail syndrome diagnosis in elder patients (Three out five criteria)
Fall Risk by test up and go
Functional tests of frail syndrome diagnosis in elder patients (<10 seconds: low fall risk; 10-20 seconds: fragility (risk of fall); >20 seconds: high risk of fall).
The Lawton Instrumental Activities of Daily Living (IADL) Scale
Functional tests of frail syndrome diagnosis in elder patients (Grade of depedence: <20: Total; 20-35: Severe; 40-55: Moderate; >60: Mild; 100: Independent).
Barthel Test for dependency
Functional tests of frail syndrome diagnosis in elder patients

Secondary Outcome Measures

Mini-Mental Test
Cognitive evaluation (0-14: severe cognitive impairment; 15-19: moderate cognitive impairment; 20-24 mild cognitive impairment; 25-30: soft deficit of cognitive function; 30-35: normal).
Short Form 36 (SF-36) Health survey Questionnaire
Questionnaire to measure quality of life (0-100 --> 0=worst health status - 100=better health status).

Full Information

First Posted
September 27, 2020
Last Updated
October 1, 2020
Sponsor
Endocrinology and Clinical Nutrition Research Center, Spain
search

1. Study Identification

Unique Protocol Identification Number
NCT04574271
Brief Title
Multidimensional Intervention in Pre-frail Patients Older Than 70 Years
Official Title
Multidimensional Intervention Directed to Pre-frail Patients Older Than 70 Years From Primary Care in a Basic Semi-urban Health Area
Study Type
Interventional

2. Study Status

Record Verification Date
October 2020
Overall Recruitment Status
Unknown status
Study Start Date
June 1, 2019 (Actual)
Primary Completion Date
June 30, 2021 (Anticipated)
Study Completion Date
June 30, 2021 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Endocrinology and Clinical Nutrition Research Center, Spain

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Aging represents a huge advance in society and a health and social challenge. Spain has one of the highest life expectancies in the world, but other countries with the same demographic characteristics are ahead of us in quality adjusted life years. Primary care setting has the main drivers of healthy aging, acting on the early stages of pre-frailty and frailty. Therefore, it is proposed a multicomponent intervention (nutritional and prescription of physical exercise) in patients older than 70 years of the Medina del Campo Health Center, with pre-frailty criteria, in order to measure the changes that this intervention produces in their mild dysfunction and whether it is capable of reversing it or delaying the progression to a state of frailty.
Detailed Description
Hypothesis: A balanced diet, with a sufficient protein intake for each patient based on the Mediterranean diet, as well as the performance of multicomponent exercise 3 times a week, delays the evolution to stages of dysfunction or disability in the pre-frail population. Objective: The main objective is to evaluate the effect of an intensive nutritional dietary treatment on the function markers in a sample of elderly people in a situation of pre-frailty. To Demonstrate the equivalence of the values obtained in terms of functional improvement through adequate exercise and diet in urban populations in a semi-urban population. To evaluate the change in analytical markers that indicate pre-frailty in patients under intensive dietary-nutritional treatment. To Study the improvement of quality of life in individuals with adequate nutrition and level of physical exercise in those over 70 years of age in pre-frailty stages, increasing the prevalence of healthy aging in our study population. Methods: - Design: This is a quasi-experimental study with a control group. Recruitment will be carried out, through random sampling, of patients over 70 years of age from the basic health area of Medina del Campo Urbano, detecting those who meet Fried's pre-frailty criteria, through the FRAIL questionnaire, being positive for pre-frailty fulfilling 1 or 2 criteria. These subjects detected as pre-frail will be randomly included in different multicomponent programs. In a group, two types of interventions will be carried out by the research team from primary care: Dietary advice adjusted to the needs of the patient and their pre-frailty stage, with an adequate nutritional and protein intake, based on the scientific evidence existing to date and in collaboration with the Clinical Hospital of Valladolid, Spain; and a multicomponent physical exercise prescription (elasticity, strength, resistance and balance), of at least 150 minutes per week, according to the WHO recommendations for this age group, adapting it individually, to be performed 3-5 times per week. Both branches of the intervention will be carried out through periodic interviews throughout a year of follow-up. In the control group, the nutritional advice and prescription of regular physical exercise will be developed by the health team of the primary care center. During this year, the parameters to be measured of functionality and independence, as well as anthropometric, quality of life and corresponding analytical parameters will be evaluated prior to the beginning of the intervention. Evaluating their variation at 3 months, 6 months and one year in both groups. Sample Size: It has been calculated to estimate a proportion similar to that of the population. Based on the prevalence of 50% existing in other study samples in the national territory for pre-frailty, and thus choosing the position of maximum indeterminacy (p = 50), assuming normality, for an α = 0.05 the Measure of the resulting sample calculated was 338 individuals. Chronogram: Selection of patients: june 2019. Phone recruiting of patients: june 2019 Clinical and functional assessment will be carried out in Medina del Campo Health Center and randomization: july 2019-August 2019. Intervention (First Time): October-december 2019; january-february 2020; july-august 2020; september-october 2020. Follow up: Evaluation of parameters. July-August 2020; september-october 2020; november-december 2020; january-february 2021. Statistycal Analysis: March-April 2021 Drafting of results: May-June 2021

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Frail Elderly Syndrome, Sarcopenia

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Intervention Group: Intensitve nutritional advice and exercise prescription adapted to physical performance. Control Group: Usual nutritional advice and exercise prescription.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
340 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Intensive dietary advice and exercise prescription
Arm Type
Experimental
Arm Description
Personalized dietary advice and exercise prescription according to nutritional status.
Arm Title
Usual dietary advice and exercise prescription
Arm Type
Active Comparator
Arm Description
Generalized dietary advice and exercise prescription in elder subjects.
Intervention Type
Behavioral
Intervention Name(s)
Intensive dietary advice and exercise prescription
Other Intervention Name(s)
Personalized dietary advice and exercise prescription
Intervention Description
Personalized dietary advice and exercise prescription according to nutritional status.
Intervention Type
Behavioral
Intervention Name(s)
Usual dietary advice and exercise prescription
Intervention Description
Generalized dietary advice and excercise prescription in elder patients.
Primary Outcome Measure Information:
Title
Functional assessment by Fried Criteria
Description
Test of frail syndrome diagnosis in elder patients (Three out five criteria)
Time Frame
12 months
Title
Fall Risk by test up and go
Description
Functional tests of frail syndrome diagnosis in elder patients (<10 seconds: low fall risk; 10-20 seconds: fragility (risk of fall); >20 seconds: high risk of fall).
Time Frame
12 months
Title
The Lawton Instrumental Activities of Daily Living (IADL) Scale
Description
Functional tests of frail syndrome diagnosis in elder patients (Grade of depedence: <20: Total; 20-35: Severe; 40-55: Moderate; >60: Mild; 100: Independent).
Time Frame
12 months
Title
Barthel Test for dependency
Description
Functional tests of frail syndrome diagnosis in elder patients
Time Frame
12 months
Secondary Outcome Measure Information:
Title
Mini-Mental Test
Description
Cognitive evaluation (0-14: severe cognitive impairment; 15-19: moderate cognitive impairment; 20-24 mild cognitive impairment; 25-30: soft deficit of cognitive function; 30-35: normal).
Time Frame
12 months
Title
Short Form 36 (SF-36) Health survey Questionnaire
Description
Questionnaire to measure quality of life (0-100 --> 0=worst health status - 100=better health status).
Time Frame
12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Non-institutionalized patients over 70 years of age from the basic health area of Medina del Campo Urbano, who meet pre-frailty criteria (1 or 2 Fried criteria). Exclusion Criteria: Cognitive impairment Frailty syndrome Moderate-Severe Dependence Life Expectancy less than 6 months or patients in palliative care
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Juan J LOPEZ-GOMEZ, MD; PhD
Phone
983420000
Ext
86158
Email
jjlopez161282@hotmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Daniel A. De Luis Román, MD; PhD
Phone
983420000
Ext
86660
Email
dadluis@yahoo.es
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Juan J LOPEZ-GOMEZ, MD; PhD
Organizational Affiliation
Hospital Clínico Universitario de Valladolid
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Daniel A De Luis Román, MD; PhD
Organizational Affiliation
University of Valladolid
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Cristina Gutiérrez-Lora, MD
Organizational Affiliation
Primary Care Center (Medina del Campo (Valladolid, Spain))
Official's Role
Principal Investigator
Facility Information:
Facility Name
Cristina Gutiérrez-Lora
City
Medina del Campo
State/Province
Valladolid
ZIP/Postal Code
47400
Country
Spain
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Cristina Gutiérrez-Lora, MD
Phone
983812750
Email
cgulora@gmail.com
First Name & Middle Initial & Last Name & Degree
Cristina Gutiérrez-Lora, MD
First Name & Middle Initial & Last Name & Degree
Daniel A De Luis-Roman, MD; PhD
First Name & Middle Initial & Last Name & Degree
Juan J López-Gomez, MD; PhD
First Name & Middle Initial & Last Name & Degree
Cristina Gutiérrez-Lora, MD
First Name & Middle Initial & Last Name & Degree
Pilar Nieto González
First Name & Middle Initial & Last Name & Degree
Nuria Gracia Rodríguez
First Name & Middle Initial & Last Name & Degree
Almudena Casas Manzanas
First Name & Middle Initial & Last Name & Degree
Miguel A García Rodríguez, MD; PhD
First Name & Middle Initial & Last Name & Degree
Ismael Calcerrada Alises
First Name & Middle Initial & Last Name & Degree
Javier Gamarra Ortiz, MD
First Name & Middle Initial & Last Name & Degree
María San Millán-González

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Multidimensional Intervention in Pre-frail Patients Older Than 70 Years

We'll reach out to this number within 24 hrs